If under no obligation, then why say anything? With 12 ID's to give Vorlon cover, this is just a ruse. Why post on a board you have a theory that you will validate after something happens. Any number of things can be fabricated after an event. Sorry I'm use to dealing with adults.
Here's how it starts. Vorlon has a theory. Next we find ID #2,3,4,5,6,7,8,9,10 all speculating that it has to do with up listing. That's how they work this everyday. The brainfart and then numerous ID's working the angle. Nice.....
This sounds like you will paint a angle on this after the facts. Pretty easy to be right after events. Amazing the stuff that some longs come up with here. Bet if we dug deep on MILL's board, he would have a similar posts. I wonder how that turned out?
Nice observation. It looks like near zero growth and investors will see further dilution. IMHO. If Honda gets scared here, they maybe monitoring the "going concern" reference by CPA's. These car companies don't like snags in their production lines.
The article in Alpha was designed to lure the low information investor in and then take advantage of it. Work exactly as they planned. If I was a bag holder here, I would be questioning that articles sponsor. Were they paid to produce that article?
Are you just another of Vorlons id's? You post identical posts on MILL that Vorlon posted. These are the games they play. Multiple ID's to make it look like they have support. The hype on BTD will be felt right before decision. As we get closer the share price will have some speculation built in. The markets have dragged down biotech's. That is obvious.
You still living in the past spandex. How low an IQ do you have? You post a question and at the end ask ,"What that cat has your tongue"...I guess in your little world, I can answer your questions while you are writing them.
Enterprise value...that's easy....Enterprise will pick you up at your door. But if you are naked they will drive off. No one wants to see that wrinkle willy of yours. Watch and learn spandex. I notice you still pretending you own shares. Well if it goes down you sold right before it and if it goes up, you holding shares. Nice call on CDTI, you only missed by .38 a share on loses. Only you could be so wrong so often!
Sentiment: Strong Buy
Eraser boy has a new ID. Eckgar1, didn't you make this same point when I had questions about trials. To debate you about things. Then you got caught erasing a post and no longer a factor here.
Thanks. Believe they have another presentation before FDA gets the next word in. The strong beliefs here resonate from some of the most immature investors. If that doesn't speak volumes, nothing does.
Pumper is the individual who pretends he has all the answers. That nothing can go wrong here. That this is a slam dunk on 28 patients. They see the FDA bending over. There's going to be one of two outcomes here and at best I can figure, we have about a 33% chance that the FDA sees it our way. I can live with 33% odds, if all the stones are turned over and examined. I changed my mind on this investment on one belief, that maybe it needed to explain the MOA. Nothing else posted here gives me any warm and fussy feeling that we have any inside track here. AACR and Hemonc didn't deliver anything concrete.
There should be more debate here. Some longs want zero debate. They act like it's their way or the highway. I'm sure of one thing, no one here really has any clue what the FDA will do.
I have an issue when the hype intensives right before the take down. Someone made a bunch shorting this, I'm sure. This is not like normal events, where primary or secondary points were met. This crossed into territory of giving me the nod, because I saw something buried in the data. We are not allowed to see the abstract, we don't have all the info from Hemonc. But somehow we should be confident that a few here have all the answers. In this market, I don't want to get caught on the wrong side of this trade. I get convinced when the ahrd questions are asked. Not when they are ignored.
I don't trust much from the pumpers here. Interesting how they pumped and pumped and we only lost $100M in valuation. When the pump begins sell shares, you will live long and prosper.
The CEO park a load of his shares in a Family partnership Trust. Little estate and tax planning going on. I like when insiders are looking at the big picture. I would not rule out a buyout. They are cleaning this balance sheet up for some reason, either way it's a Win/Win for investors.
Sentiment: Strong Buy
Here's the Pr about the latest conference:
Dr. Robert H.I. Andtbacka, associate professor in the Division of Surgical Oncology, Department of Surgery at the University of Utah School of Medicine, will moderate Session 4: Local and Regional Therapy. Session 4 will be held on Friday, April 11 at 2:15 pm. Sanjiv S. Agarwala, MD, Program Director of the Conference, has said data regarding “PV-10 will be an integral part of session 4.” Provectus has recently submitted an application to the FDA for breakthrough therapy designation for PV-10 based on the results from its Phase 2 clinical study.
We have had two conferences and no real news. The best explanation about the latest conference was that since we weren't mentioned in one discussion, that somehow benefits us. I heard it all here. Well what did they present in this session 4 about our drug?
Too busy doing unethical things. Unethical companies are not good investments. Investors here overlooked too many warning signs.
They do seem to pump and hide. Well someone made off with $100M recently. Be careful of who leads the charge and then retreats, behind the lines.
I don't see your name on a door at the FDA either. I'm just not fooling myself in to believing that some how our drug defies all the odds. We have seen something like $80M in valuation go bye bye again, at the same time the hype on these boards increased.
I believe investors are betting that a bridging study will be required before approval. BTD will be decided before ASCO, so we are left with a probability of BTD. The hype here has failed miserably and my feeling is that the pumpers are the ones dumping shares. We lost site of what is real here. That the FDA will be left with a difficult choice and when that happens, they will lean towards asking for more data. Sam I is I am, here wants you to view this as an industry problem. Longs have an excuse for Everything here. Voted the most excuse giving board on Yahoo.
"we could" was used how many times by this analyst? Good find. Company needs to update on those two other MSA agreements. If revenue's reach the upper level, a GAAP profit is almost guaranteed. We still have a weak quarter to get past. But with the right emphasis on the next three quarters growth, we should be heading higher. Weather is perfect right now to be hitting on all cylinders. The biggest benefit is in Oil and Gas where the turn around is at least a $40M-$75M Operating profit improvement over last year.
Those insiders were loading up for a reason.